RightFit
RecruitingNot applicable

Centralized Screening Unit (CSU) at Montefiore-Einstein

Implementation of a Centralized Screening Unit at Montefiore-Einstein

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
50 Years to 77 Years
Sex
All sexes
Healthy volunteers
Accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Procedures mentioned: CT scans

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Despite strong evidence that Lung-cancer screening (LCS) can reduce Lung cancer (LCa) deaths, low-dose computed tomography (LDCT) referral rates by clinicians are very low and there is poor adherence with LCS by patients."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

In plain language

This study tests whether a central screening team can help more people get and keep up with lung cancer screening in the Bronx, New York. It is for adults ages 50–77 with a history of heavy smoking. The study also tests whether this support leads to fewer lung cancers being found at a late stage.

This study proposes to increase Lung-cancer screening (LCS) in the Bronx, New York. Despite strong evidence that Lung-cancer screening (LCS) can reduce Lung cancer (LCa) deaths, low-dose computed tomography (LDCT) referral rates by clinicians are very low and there is poor adherence with LCS by patients. Both provider and patient barriers may be amenable to systemic improvements in support, coordination and infrastructure for screening. The investigator team hypothesizes that the implementation of a Central Screening Unit (CSU) that shifts routine workflow attributed to LCS (e.g., collection of smoking history, determination of eligibility, shared decision making and arranging follow-up) away from busy practices (usual care) and that offers patients an array of navigation and support services will increase the uptake of LCS guidelines and subsequent low-dose computed tomography (LDCT) screening scans in a low-income, predominately Hispanic and Black catchment area. The proposed study represents a unique opportunity to test this hypothesis in the context of the roll out of a CSU as a significant new component of the Montefiore-Einstein health system. The investigator team will examine whether and how the CSU facilitates LCS uptake and retention of patients. This study is powered to test whether CSU reduces proportion of late-stage lung cancer diagnoses in the Bronx, New York.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Who can join

  • Clinics must be part of NYC RING and agree to follow the study plan.
  • Patients must be ages 50–77.
  • Must smoke now or have quit within the past 15 years.
  • Must have smoked at least 20 pack-years—for example, 1 pack a day for 20 years or 2 packs a day for 10 years.
  • Must not have had a chest CT scan, which takes detailed pictures inside the chest, in the past 12 months.
  • Must have no history of lung cancer. If another cancer was diagnosed, it must have been at least 5 years ago.

Who can't join

  • Clinics that treat only children.
  • Clinics that do not agree to follow the study plan.
  • Patients whose primary care provider says not to contact them for any reason.
  • Anyone contacted by mistake who does not meet the study rules.

Simplified for readability. The official criteria below are what the study team uses.

Official eligibility criteria

Inclusion Criteria: Clinic level: * a NYC RING affiliated clinic, * Opt into and agree to research protocol; Patient level: * Age 50-77 for participants, * past or current smoker, * 20+ pack-years tobacco, * has quit smoking within the last 15 years, * without chest CT within the past 12 months, and, * no history of lung cancer or and at least 5 years since the diagnosis of any other malignancy Exclusion Criteria: Clinic level: * only treats pediatric patients, * Opt out of research protocol; Patient level: * Primary care provider instruction to not contact an individual for any reason. Any individual inadvertently contacted who does not meet these criteria will be excluded from the study.

Study sites (1)

NY